Skip to content

NEOGEN DEVELOPMENTS

Absorbed by Neogen NV KBO/BCE: BE 0808.426.110 subsidiary of Alter Pharma Group NV
NEOGEN DEVELOPMENTS
Financial year 2019
Follow Report

Annual accounts 2019

abbreviated format, filed on 14-07-2020, 17 days before the deadline
-€16,779
-€66,953
▼ €43,436
-
-
41.2%
▲ 1.4 percentage points
1.70
▼ 1.89

Money flows

no detail for 2019

Balance sheet

balance sheet total €710,375 on 31-12-2019
What the company ownsHow it is paid for

in euro

in euro

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2019201820172016201520142013201220112010
Balance sheet: assets
20/58 710,375928,7472.8m3.1m1.9m4.2m3.6m3.3m1.3m51,080
21/28 -------290581-
22/27 -------290581-
23 -------290581-
29/58 710,375928,7472.8m3.1m1.9m4.2m3.6m3.3m1.3m51,080
3 --417,532296,402176,099423,963583,553604,027--
30/36 --417,532296,402176,099423,963583,553604,027--
30/31 --417,532235,166103,001271,448212,122---
34 ---61,23673,098152,515371,431---
40/41 652,387860,5221.8m2.7m1.6m3.4m2.5m2.6m1.3m39,580
40 121,547278,834987,1511.0m884,8931.8m1.0m1.8m76,426-
41 530,840581,688767,7411.7m745,9491.6m1.5m756,8871.2m39,580
54/58 57,98868,225641,34064,92050,36439,808146,246158,17975611,500
490/1 -----336,000436,000---
Balance sheet: equity and liabilities
10/49 710,375928,7472.8m3.1m1.9m4.2m3.6m3.3m1.3m51,080
10/15 292,526369,248309,933225,566181,102117,32547,02074,04252,59049,862
10/11 61,50061,50061,50061,50061,50061,50061,50061,50061,50061,500
100 61,50061,50061,50061,50061,50061,50061,50061,50061,50061,500
13 6,1506,1506,1506,1506,1506,1506,1506,150--
130 6,1506,1506,1506,1506,1506,1506,1506,150--
14 224,876301,598242,283157,916113,45249,675-20,6306,392-8,910-11,638
17/49 417,848559,4992.5m2.8m1.7m4.1m3.6m3.3m1.2m1,218
17 -300,399---25,712176,359287,144459,787-
170/4 -300,399---25,712176,359287,144459,787-
173 -300,399---25,712176,359---
42/48 417,848258,8242.5m2.8m1.7m4.1m3.4m2.6m752,5711,218
42 ----25,712150,647144,611172,643133,255-
43 --300,000300,000300,000300,000300,000300,000300,000-
430/8 --300,000300,000300,000300,000300,000300,000300,000-
44 96,444169,4362.2m2.5m1.2m3.6m3.0m2.1m319,3161,218
440/4 96,444169,4362.2m2.5m1.2m3.6m3.0m2.1m319,3161,218
45 -30,77841,98139,00070,00037,000-47,784--
450/3 -30,77841,98139,00070,00037,000-47,784--
47/48 321,40458,611--105,124-----
492/3 -276-----386,461--
Income statement
70/76A -227,0804.2m5.0m3.3m7.6m9.4m---
70 -108,2014.1m4.9m3.3m7.6m9.4m---
9900 -16,779------38,23222,256-10,896
60/66A -250,5974.1m4.9m2.9m7.5m9.4m---
60 --2.1m2.5m1.6m4.0m6.6m---
600/8 --2.2m2.6m1.4m3.9m6.5m---
609 ---121,130-120,303247,864133,40620,474---
61 -253,1972.0m2.3m1.2m3.4m2.7m---
630 ------290290291-
631/4 49,306-3,468-39,122-5,7761,698138,80725,000---
640/8 86886892,207127,77088,27313,528114,486452366742
9901 -66,953-23,517106,803116,661387,252129,33034537,49021,599-11,638
75/76B 2,0816,27525,24513,02268,932102,2847,23723,43012,965-
75 2,0816,27525,24513,02268,932102,2847,23723,43012,965-
751 -6,27224,5573,99968,603102,0166,553---
752/9 -36889,023329269684---
65/66B 11,8508,7258,53815,836359,407124,30934,47937,19731,818-
65 11,8508,7258,53815,836359,407124,30934,47937,19731,818-
650 -8,0855,8686,48111,49216,62823,440---
651 ----336,000100,000----
652/9 -6402,6709,35511,9157,68111,038---
9903 -76,722-25,968123,511113,84796,777107,305-26,89723,7242,746-11,638
67/77 --6,22239,14369,38333,00037,0001242,27218-
670/3 -30,77841,98169,38333,00037,000124---
77 -37,0002,838-------
9904 -76,722-19,74584,36744,46463,77770,305-27,02221,4522,728-11,638
9905 -76,722-19,74584,36744,46463,77770,305-27,02221,4522,728-11,638
Appropriation of the result
9906 224,876301,598242,283157,916113,45249,675-20,63012,542-8,910-11,638
691/2 -------6,150--
6920 -------6,150--
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

Source: Annual accounts 2019 (PDF), filed on 14-07-2020.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2019 abbreviated format 14-07-2020 2020-30400482 PDF
31-12-2018 full format 09-07-2019 2019-31200391 PDF
31-03-2018 full format 26-10-2018 2018-70400420 PDF
31-03-2017 full format 08-11-2017 2017-69500061 PDF
31-03-2016 full format 25-10-2016 2016-66200366 PDF
31-03-2015 full format 19-10-2015 2015-65300042 PDF
31-03-2014 full format 28-10-2014 2014-65800187 PDF
31-03-2013 full format 31-10-2013 2013-65000601 PDF
31-03-2012 abbreviated format 25-10-2012 2012-61900563 PDF
31-03-2011 abbreviated format 28-11-2011 2011-62100169 PDF
31-03-2010 abbreviated format 27-09-2010 2010-55300398 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2019201820172016201520142013201220112010
------63537,78121,890-
-------26,73121,7423,019-
------0-0871-
-10,237-573,115576,42014,55610,556-106,438-11,933157,423-10,744-
292,526669,922309,933225,566181,102143,037223,379747,357511,79649,862
--21.7%2.6%2.4%11.8%1.7%0.0%---
41.2%39.8%11.0%7.4%9.8%2.8%1.3%2.2%4.2%97.6%
1.703.591.121.081.111.041.071.291.6841.94
1.703.590.960.971.000.930.891.061.6841.94
1.431.528.0812.559.2634.7976.2843.9123.050.02
-26.2%-5.3%27.2%19.7%35.2%59.9%-57.5%29.0%5.2%-23.3%
-10.8%-2.1%3.0%1.5%3.4%1.7%-0.7%0.6%0.2%-22.8%
------0.03---
-941 days88 days75 days98 days85 days40 days---
-244 days197 days190 days151 days177 days117 days---

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on NEOGEN DEVELOPMENTS

The operating result for 2019 is a loss of €66,953, larger than the loss of €23,517 in 2018. It is the lowest result since 2010.

Debt's share of the balance-sheet total falls from 60.2% to 58.8%. Equity and debt are lower.

We would like to set cookies. That happens only with your consent. What we measure